Display options
Share it on

Beilstein J Org Chem. 2015 Oct 16;11:1922-32. doi: 10.3762/bjoc.11.208. eCollection 2015.

Synthesis, antimicrobial and cytotoxicity evaluation of new cholesterol congeners.

Beilstein journal of organic chemistry

Mohamed Ramadan El Sayed Aly, Hosam Ali Saad, Shams Hashim Abdel-Hafez

Affiliations

  1. Chemistry Department, Faculty of Science, Taif University, 21974-Hawyah-Taif, Kingdom of Saudi Arabia ; Chemistry Department, Faculty of Applied Science, Port Said University, 42522-Port Said, Egypt.
  2. Chemistry Department, Faculty of Science, Taif University, 21974-Hawyah-Taif, Kingdom of Saudi Arabia ; Chemistry Department, Faculty of Science, Zagazig University, Zagazig, 44511, Egypt.
  3. Chemistry Department, Faculty of Science, Taif University, 21974-Hawyah-Taif, Kingdom of Saudi Arabia ; Chemistry Department, Faculty of Science, Assuit University, 71516-Assuit, Egypt.

PMID: 26664612 PMCID: PMC4661006 DOI: 10.3762/bjoc.11.208

Abstract

3β-Azidocholest-5-ene (3) and (3β)-3-(prop-2-yn-1-yloxy)cholest-5-ene (10) were prepared as substrates to synthesize a variety of three-motif pharmacophoric conjugates through CuAAC. Basically, these conjugates included cholesterol and 1,2,3-triazole moieties, while the third, the pharmacophore, was either a chalcone, a lipophilic residue or a carbohydrate tag. These compounds were successfully prepared in good yields and characterized by NMR, MS and IR spectroscopic techniques. Chalcone conjugate 6c showed the best antimicrobial activity, while the lactoside conjugate 27 showed the best cytotoxic effect in vitro.

Keywords: antimicrobial; chalcone; cholesterol; cytotoxicity; glycoside; triazole

References

  1. Bioorg Med Chem Lett. 2013 Sep 15;23(18):5165-9 - PubMed
  2. Bioorg Med Chem Lett. 2013 Apr 1;23(7):2162-5 - PubMed
  3. Histol Histopathol. 2006 Oct;21(10):1029-41 - PubMed
  4. Bioorg Med Chem Lett. 2013 Oct 1;23(19):5356-60 - PubMed
  5. Prostate. 2011 Nov;71(15):1668-79 - PubMed
  6. J Steroid Biochem Mol Biol. 1992 Dec;43(8):779-804 - PubMed
  7. Genomics. 1994 May 1;21(1):150-9 - PubMed
  8. Org Lett. 2009 Feb 5;11(3):567-70 - PubMed
  9. Chem Soc Rev. 2014 Oct 7;43(19):6672-82 - PubMed
  10. Chembiochem. 2014 Sep 22;15(14):2087-96 - PubMed
  11. Cancer Lett. 2010 Dec 28;299(2):95-110 - PubMed
  12. Infect Immun. 2011 Jan;79(1):88-97 - PubMed
  13. Antimicrob Agents Chemother. 2009 Dec;53(12):5088-94 - PubMed
  14. Bioorg Med Chem Lett. 2015 Jul 15;25(14):2824-30 - PubMed
  15. Am J Clin Pathol. 1966 Apr;45(4):493-6 - PubMed
  16. Adv Healthc Mater. 2014 Jun;3(6):882-9 - PubMed
  17. Eur J Med Chem. 2014 Apr 9;76:517-30 - PubMed
  18. J Am Chem Soc. 2012 Mar 21;134(11):5351-61 - PubMed
  19. Carbohydr Res. 2006 Jul 24;341(10):1353-62 - PubMed
  20. Cell Rep. 2012 Sep 27;2(3):580-90 - PubMed
  21. Antimicrob Agents Chemother. 2011 Jun;55(6):2897-904 - PubMed
  22. Glycoconj J. 1989;6(1):67-83 - PubMed
  23. Redox Biol. 2013 Jan 31;1:125-30 - PubMed
  24. Angew Chem Int Ed Engl. 2002 Jul 15;41(14):2596-9 - PubMed
  25. Microbiology (Reading). 2007 Jun;153(Pt 6):1677-1692 - PubMed
  26. J Food Prot. 2005 Feb;68(2):282-91 - PubMed
  27. Nanomedicine. 2009 Dec;5(4):457-62 - PubMed
  28. J Med Chem. 2005 Oct 20;48(21):6750-5 - PubMed
  29. Nutrition. 2011 Jun;27(6):700-6 - PubMed
  30. Bioorg Med Chem Lett. 2013 Sep 1;23(17):4806-12 - PubMed
  31. Nat Commun. 2013;4:1840 - PubMed
  32. J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12 - PubMed
  33. Bioorg Khim. 2012 Jul-Aug;38(4):489-95 - PubMed
  34. Theranostics. 2012;2(11):1092-103 - PubMed

Publication Types